A detailed history of Handelsbanken Fonder Ab transactions in Johnson & Johnson stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 1,474,927 shares of JNJ stock, worth $245 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares
1,474,927
Previous 1,379,192 6.94%
Holding current value
$245 Million
Previous $218 Million 1.19%
% of portfolio
0.94%
Previous 0.94%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$144.38 - $157.78 $13.8 Million - $15.1 Million
95,735 Added 6.94%
1,474,927 $216 Million
Q1 2024

May 13, 2024

SELL
$155.22 - $162.74 $3.43 Million - $3.59 Million
-22,080 Reduced 1.58%
1,379,192 $218 Million
Q4 2023

Feb 01, 2024

SELL
$145.6 - $158.88 $4.94 Million - $5.39 Million
-33,940 Reduced 2.36%
1,401,272 $220 Million
Q3 2023

Oct 19, 2023

SELL
$155.75 - $174.48 $5.35 Million - $6 Million
-34,360 Reduced 2.34%
1,435,212 $224 Million
Q2 2023

Aug 02, 2023

SELL
$154.35 - $166.11 $14.2 Million - $15.3 Million
-91,833 Reduced 5.88%
1,469,572 $243 Million
Q1 2023

Apr 28, 2023

SELL
$151.05 - $180.26 $5.72 Million - $6.83 Million
-37,893 Reduced 2.37%
1,561,405 $242 Million
Q4 2022

Feb 07, 2023

BUY
$160.2 - $179.79 $16.2 Million - $18.2 Million
101,435 Added 6.77%
1,599,298 $283 Million
Q3 2022

Oct 27, 2022

BUY
$161.33 - $179.52 $16.2 Million - $18 Million
100,444 Added 7.19%
1,497,863 $245 Million
Q2 2022

Aug 03, 2022

BUY
$168.19 - $186.01 $17.4 Million - $19.2 Million
103,445 Added 7.99%
1,397,419 $248 Million
Q1 2022

May 11, 2022

SELL
$158.14 - $179.59 $2.93 Million - $3.33 Million
-18,539 Reduced 1.41%
1,293,974 $229 Million
Q4 2021

Feb 08, 2022

SELL
$155.93 - $173.01 $13.5 Million - $15 Million
-86,438 Reduced 6.18%
1,312,513 $225 Million
Q3 2021

Nov 10, 2021

BUY
$161.5 - $179.47 $9.42 Million - $10.5 Million
58,348 Added 4.35%
1,398,951 $226 Million
Q2 2021

Aug 03, 2021

BUY
$159.48 - $171.07 $1.83 Million - $1.96 Million
11,463 Added 0.86%
1,340,603 $221 Million
Q1 2021

Apr 29, 2021

BUY
$153.07 - $170.48 $26.6 Million - $29.7 Million
173,955 Added 15.06%
1,329,140 $218 Million
Q4 2020

Feb 11, 2021

BUY
$137.11 - $157.38 $6.68 Million - $7.67 Million
48,728 Added 4.4%
1,155,185 $182 Million
Q3 2020

Nov 13, 2020

SELL
$140.38 - $153.83 $1.06 Million - $1.16 Million
-7,547 Reduced 0.68%
1,106,457 $165 Million
Q2 2020

Aug 13, 2020

BUY
$128.81 - $155.51 $107 Million - $129 Million
829,053 Added 290.95%
1,114,004 $157 Million
Q1 2020

May 14, 2020

BUY
$111.14 - $153.99 $4.11 Million - $5.7 Million
37,000 Added 14.92%
284,951 $37.4 Million
Q4 2019

Feb 14, 2020

SELL
$127.5 - $146.44 $8.27 Million - $9.5 Million
-64,900 Reduced 20.74%
247,951 $36.2 Million
Q3 2019

Oct 31, 2019

SELL
$126.95 - $142.14 $5.72 Million - $6.4 Million
-45,041 Reduced 12.59%
312,851 $40.5 Million
Q2 2019

Jul 12, 2019

SELL
$131.15 - $144.24 $28.1 Million - $30.9 Million
-214,322 Reduced 37.45%
357,892 $49.8 Million
Q1 2019

May 10, 2019

SELL
$125.72 - $139.79 $37.7 Million - $41.9 Million
-299,557 Reduced 34.36%
572,214 $80 Million
Q4 2018

Jan 31, 2019

BUY
$122.84 - $147.84 $8.45 Million - $10.2 Million
68,788 Added 8.57%
871,771 $113 Million
Q3 2018

Oct 23, 2018

BUY
$121.58 - $142.88 $97.6 Million - $115 Million
802,983 New
802,983 $111 Million
Q3 2018

Oct 19, 2018

SELL
$121.58 - $142.88 $78.2 Million - $91.9 Million
-643,084 Closed
0 $0
Q2 2018

Jul 11, 2018

BUY
$119.4 - $131.76 $1.27 Million - $1.4 Million
10,638 Added 1.68%
643,084 $78 Million
Q1 2018

May 18, 2018

SELL
$125.1 - $148.14 $62,550 - $74,070
-500 Reduced 0.08%
632,446 $81 Million
Q4 2017

Feb 08, 2018

BUY
$131.22 - $143.62 $6.27 Million - $6.87 Million
47,820 Added 8.17%
632,946 $88.4 Million
Q3 2017

Oct 24, 2017

BUY
$129.47 - $135.38 $75.8 Million - $79.2 Million
585,126
585,126 $76.1 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $434B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Handelsbanken Fonder Ab Portfolio

Follow Handelsbanken Fonder Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.